Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus
Background Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen ac...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2015-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=Zakaria |
id |
doaj-d5c264da54dd4136a48c00cdfcc9838b |
---|---|
record_format |
Article |
spelling |
doaj-d5c264da54dd4136a48c00cdfcc9838b2020-11-25T04:06:07ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982015-01-0127310811410.4103/1110-7782.165450Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitusEbtessam ZakariaMaha Hossam Al-DinNashwa S GhanemNoha A SadikMaha AssemFatma TahaBackground Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen activator (t-PA) with urinary albumin excretion (UAE) and renal disease progression in type 2 diabetes. Patients and methods A total of 50 patients with type 2 diabetes and 10 healthy control individuals were included in the study. Participants were subdivided according to UAE. Group 1 (G1) represented control individuals. Group 2 (G2) included patients without albuminuria. Group 3 (G3) included patients with microalbuminuria. Group 4 (G4) included patients with macroalbuminuria. Creatinine clearance and UAE were calculated. PAI-1 and t-PA were measured using an enzyme-linked immunosorbent assay kit, and the PAI-1/t-PA ratio was calculated as an index of impaired fibrinolysis. Results PAI-1 was highly elevated significantly in G4 when compared with the other groups, with a mean of 87.40 ± 17.03 IU/ml against 28.00 ± 6.98 IU/ml in G1, 46.4 ± 7.99 IU/ml in G2, and 64.10 ± 18.26 IU/ml in G3 (P < 0.001). Also, the serum level of t-PA in G4 was highly elevated significantly when compared with G1 and G2 with means of 16.85 ± 5.63 IU/ml against 7.95 ± 1.91 IU/ml and 10.45 ± 2.63 IU/ml, respectively (P < 0.001). The ratio of PAI-1/t-PA in G4 was significantly higher when compared with G1 (mean of 5.94 ± 2.81 against 3.54 ± 0.43; P = 0.01). PAI-1 and t-PA showed a significant positive correlation with UAE. Receiver operating characteristics curve analysis revealed that only PAI-1 and t-PA were significant discriminated factors for microalbuminuria and macroalbuminuria (P < 0.001). Conclusion Serum levels of PAI-1 and t-PA and the PAI-1/t-PA ratio were significantly increased in diabetic patients with higher UAE. Impaired fibrinolysis and increased UAE were associated with renal disease progression.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=ZakariaDiabetic nephropathy, impaired fibrinolysis, urinary albumin excretion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ebtessam Zakaria Maha Hossam Al-Din Nashwa S Ghanem Noha A Sadik Maha Assem Fatma Taha |
spellingShingle |
Ebtessam Zakaria Maha Hossam Al-Din Nashwa S Ghanem Noha A Sadik Maha Assem Fatma Taha Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus The Egyptian Journal of Internal Medicine Diabetic nephropathy, impaired fibrinolysis, urinary albumin excretion |
author_facet |
Ebtessam Zakaria Maha Hossam Al-Din Nashwa S Ghanem Noha A Sadik Maha Assem Fatma Taha |
author_sort |
Ebtessam Zakaria |
title |
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
title_short |
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
title_full |
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
title_fullStr |
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
title_full_unstemmed |
Urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
title_sort |
urinary albumin excretion and progression of renal disease with impaired fibrinolytic activity in type 2 diabetes mellitus |
publisher |
SpringerOpen |
series |
The Egyptian Journal of Internal Medicine |
issn |
1110-7782 2090-9098 |
publishDate |
2015-01-01 |
description |
Background
Diabetic nephropathy is one of the major causes of end-stage renal disease. As impaired fibrinolysis can increase renal fibrosis, we investigated the relationship of impaired fibrinolysis, as assessed by the ratio of plasminogen activator inhibitor-1 (PAI-1) to tissue-type plasminogen activator (t-PA) with urinary albumin excretion (UAE) and renal disease progression in type 2 diabetes.
Patients and methods
A total of 50 patients with type 2 diabetes and 10 healthy control individuals were included in the study. Participants were subdivided according to UAE. Group 1 (G1) represented control individuals. Group 2 (G2) included patients without albuminuria. Group 3 (G3) included patients with microalbuminuria. Group 4 (G4) included patients with macroalbuminuria. Creatinine clearance and UAE were calculated. PAI-1 and t-PA were measured using an enzyme-linked immunosorbent assay kit, and the PAI-1/t-PA ratio was calculated as an index of impaired fibrinolysis.
Results
PAI-1 was highly elevated significantly in G4 when compared with the other groups, with a mean of 87.40 ± 17.03 IU/ml against 28.00 ± 6.98 IU/ml in G1, 46.4 ± 7.99 IU/ml in G2, and 64.10 ± 18.26 IU/ml in G3 (P < 0.001). Also, the serum level of t-PA in G4 was highly elevated significantly when compared with G1 and G2 with means of 16.85 ± 5.63 IU/ml against 7.95 ± 1.91 IU/ml and 10.45 ± 2.63 IU/ml, respectively (P < 0.001). The ratio of PAI-1/t-PA in G4 was significantly higher when compared with G1 (mean of 5.94 ± 2.81 against 3.54 ± 0.43; P = 0.01). PAI-1 and t-PA showed a significant positive correlation with UAE. Receiver operating characteristics curve analysis revealed that only PAI-1 and t-PA were significant discriminated factors for microalbuminuria and macroalbuminuria (P < 0.001).
Conclusion
Serum levels of PAI-1 and t-PA and the PAI-1/t-PA ratio were significantly increased in diabetic patients with higher UAE. Impaired fibrinolysis and increased UAE were associated with renal disease progression. |
topic |
Diabetic nephropathy, impaired fibrinolysis, urinary albumin excretion |
url |
http://www.esim.eg.net/article.asp?issn=1110-7782;year=2015;volume=27;issue=3;spage=108;epage=114;aulast=Zakaria |
work_keys_str_mv |
AT ebtessamzakaria urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus AT mahahossamaldin urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus AT nashwasghanem urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus AT nohaasadik urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus AT mahaassem urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus AT fatmataha urinaryalbuminexcretionandprogressionofrenaldiseasewithimpairedfibrinolyticactivityintype2diabetesmellitus |
_version_ |
1724432377856393216 |